Loading...

Categories

13 North America Hyperglycemics Reports

North America Insulin Industry

Region Covered: North America

Study Period: 2019 - 2029

Countries Covered: United States, Canada

Major Players: Sanofi S.A., Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc, Biocon Limited

North America SGLT2 Inhibitors Market

Region Covered: North America

Study Period: 2019 - 2029

Countries Covered: United States, Canada

Major Players: Janssen Pharmaceutical, Eli Lilly, AstraZeneca Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Astellas

North America Biguanides Market

Region Covered: North America

Study Period: 2019- 2029

Countries Covered: United States, Canada

Major Players: Sanofi Aventis, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Merck & Co., Inc.

North America Sulfonylureas Industry

Region Covered: North America

Study Period: 2018 - 2029

Countries Covered: United States, Canada

Major Players: Mylan, Lupin, Merck and Co., Pfizer Inc., Sanofi Aventis

North America Meglitinide Industry

Region Covered: North America

Study Period: 2018 - 2029

Countries Covered: United States, Canada

Major Players: Novo Nordisk, Glenmark, Novartis, KISSEI, Biocon

Insulin Market

Region Covered: North America

Study Period: 2019 - 2029

Countries Covered: United States, Canada, France, Germany, Italy, Spain, United Kingdom, Russia, Mexico, Brazil, Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Pfizer Inc.

Biguanides Market

Region Covered: North America

Study Period: 2018 - 2029

Countries Covered: United States, Canada, Germany, Spain, Italy, France, United Kingdom, Russia, Japan, China, Australia, India, South Korea, Malaysia, Indonesia, Thailand, Philippines, Vietnam, Brazil, Mexico, South Africa, Saudi Arabia, Oman, Egypt, Iran

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.

Meglitinides Market

Region Covered: North America

Study Period: 2019- 2029

Countries Covered: United States, Canada, Germany, Spain, Italy, France, United Kingdom, Russia, Japan, China, Australia, India, South Korea, Malaysia, Indonesia, Thailand, Vietnam, Philippines, Brazil, Mexico, South Africa, Saudi Arabia, Oman, Egypt, Iran

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

Sulfonylureas Industry

Region Covered: North America

Study Period: 2019- 2029

Countries Covered: United States, Canada, France, Germany, Italy, Spain, United Kingdom, Russia, Mexico, Brazil, Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

SGLT2 Inhibitors Market

Region Covered: North America

Study Period: 2019 - 2029

Countries Covered: United States, Canada, France, Germany, Italy, Spain, United Kingdom, Russia, Mexico, Brazil, Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Basal Insulin (Long-Acting Insulin) Market

Region Covered: North America

Study Period: 2019 - 2029

Countries Covered: United States, Canada, Germany, Spain, Italy, France, United Kingdom, Russia, Japan, China, Australia, India, South Korea, Malaysia, Indonesia, Thailand, Philippines, Vietnam, Brazil, Mexico, South Africa, Saudi Arabia, Oman, Egypt, Iran

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Fibrate Drugs Market

Region Covered: North America

Study Period: 2019 - 2029

Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina

Major Players: Abbott, Sanofi , Mylan Inc, Lupin, Aurobindo Pharma

Glargine Insulin Market

Region Covered: North America

Study Period: 2018 - 2029

Countries Covered: United States, Canada, France, Germany, Italy, Spain, United Kingdom, Russia, Mexico, Brazil, Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Filter Reports

By Countries